‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and approval process in the U.S., but Makary we expect will promote technology and innovation in a way that offers some reprieve for those that feared a department more aligned with different virtues.
BridgeBio, FDA
President-elect Donald Trump announced several additional nominations to positions involving national health, labor and ...
President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.
The U.S. Food and Drug Administration announced a recall of Umary supplements due to a contamination of two over-the-counter ...
Medpage Today on MSN16h
Trump's FDA Pick Is MedPage Today's Former Top EditorOutgoing FDA Commissioner Robert Califf, MD, has fought against medical misinformation, and pushed for improvements in food ...
Own stocks of companies that get drugs approved. That hasn’t been so easy. But the U.S. Food & Drug Administration (FDA) has ...
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to ...
Kennedy Jr. are weighing a significant rewrite to the Food and Drug Administration's rules governing food additives, to ...
The affected products contain Listeria monocytogenes, a deadly bacterium that kills around 260 people in the U.S. each year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback